Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China flag China · Delayed Price · Currency is CNY
22.44
+0.22 (0.99%)
Apr 28, 2026, 3:04 PM CST

SHE:002262 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,4241,4501,4162,1591,5321,608
Trading Asset Securities
2,7062,5692,3731,3351,4521,058
Cash & Short-Term Investments
4,1304,0193,7893,4942,9842,666
Cash Growth
3.41%6.05%8.46%17.08%11.94%19.05%
Accounts Receivable
1,8301,5671,4961,054843.93720.49
Other Receivables
76.3269.6549.0741.8442.5227.61
Receivables
1,9071,6371,5451,095886.45748.09
Inventory
695.23756.78661.39628.64716.34604.33
Prepaid Expenses
-1.275.45004.81
Other Current Assets
142.549.4157.8436.6363.419.96
Total Current Assets
6,8756,4636,0605,2554,6504,043
Property, Plant & Equipment
1,5941,6341,6091,4961,3041,158
Long-Term Investments
197.49195.07125.31106.77118.61130.41
Other Intangible Assets
285.19249.08232.09190.47111.195.98
Long-Term Deferred Tax Assets
75.7873.955.3958.3236.9530.66
Long-Term Deferred Charges
497.13529.03263.61128.03131.8880.51
Other Long-Term Assets
118.1278.9895.294.05128.51158.09
Total Assets
9,6439,2238,4407,3286,4815,697
Accounts Payable
622.34556.95568.35277.2255.74267.17
Accrued Expenses
0.17313.82180.54296.13297.3653.09
Short-Term Debt
613015553038
Current Portion of Leases
18.1517.7920.1820.8620.6325.01
Current Income Taxes Payable
151.6834.9391.2884.183.580.85
Current Unearned Revenue
70.1130.0141.5326.4926.724.11
Other Current Liabilities
283.88108.73149.3754.2680.02193.72
Total Current Liabilities
1,2071,0921,066814.03793.94681.96
Long-Term Debt
0.230.230.230.230.230.23
Long-Term Leases
15.5719.6933.8735.5641.9147.67
Long-Term Unearned Revenue
49.6349.6341.4153.8758.0563.6
Long-Term Deferred Tax Liabilities
--0.111.463.3-
Other Long-Term Liabilities
24.3733.5424.6412.95--
Total Liabilities
1,2971,1951,166918.09897.43793.45
Common Stock
1,0161,0161,0161,0081,0081,008
Additional Paid-In Capital
281.3281.3244.18102.99119.41119.41
Retained Earnings
7,1476,8296,1385,3174,4813,783
Treasury Stock
-68.3-68.3-98.86---
Comprehensive Income & Other
-1.11-1.110.876.7513.110.95
Total Common Equity
8,3758,0577,3006,4345,6224,921
Minority Interest
-29.05-29.24-26.81-24.03-37.79-16.96
Shareholders' Equity
8,3458,0287,2746,4105,5844,904
Total Liabilities & Equity
9,6439,2238,4407,3286,4815,697
Total Debt
94.9567.7269.27111.6492.77110.91
Net Cash (Debt)
4,0353,9513,7203,3822,8912,555
Net Cash Growth
2.57%6.20%9.99%16.98%13.16%16.08%
Net Cash Per Share
3.993.923.683.362.862.53
Filing Date Shares Outstanding
1,0161,0161,0161,0081,0081,008
Total Common Shares Outstanding
1,0161,0161,0161,0081,0081,008
Working Capital
5,6675,3714,9934,4413,8563,361
Book Value Per Share
8.247.937.186.395.584.88
Tangible Book Value
8,0897,8087,0686,2445,5104,825
Tangible Book Value Per Share
7.967.696.966.205.474.79
Buildings
-657.02613.6599.08593.38569.55
Machinery
-1,5971,5461,3411,2511,088
Construction In Progress
-365.94309.38293.7692.0717.21
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.